Finance

Lists
Why is 1734 down 2.01%?
Dive Deeper
1734:TPE
Sinphar Pharmaceutical Co Ltd
NT$31.75
-2.01%
(-0.65) 1D
Oct 12, 1:30:21 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1734...
Open
NT$32.40
High
NT$32.55
Low
NT$31.50
Mkt. cap
6.40B
Avg. vol.
198.42K
Volume
238.61K
Dividend
2.97%
Quarterly dividend
NT$0.24
Ex-dividend date
Jul 24, 2026
P/E ratio
18.23
52-wk high
NT$32.80
52-wk low
NT$28.11
EPS
NT$1.74
Shares outstanding
167.72M
No. of employees
984
Open
NT$32.40
High
NT$32.55
Low
NT$31.50
Mkt. cap
6.40B
Avg. vol.
198.42K
Volume
238.61K
Dividend
2.97%
Quarterly dividend
NT$0.24
Ex-dividend date
Jul 24, 2026
P/E ratio
18.23
52-wk high
NT$32.80
52-wk low
NT$28.11
EPS
NT$1.74
Shares outstanding
167.72M
No. of employees
984
News stories
From web sources and news partners
About Sinphar Pharmaceutical Co Ltd
CEO-
Employees984
Founded1977
HeadquartersDongshan Township, Yilan County, Taiwan
SectorPharmaceutical industry
Websitesinphar.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
872.73M
880.02M
826.63M
871.15M
Cost of goods sold
490.24M
495.03M
464.18M
462.81M
Cost of revenue
490.24M
495.03M
464.18M
462.81M
Research and development expenses
40.00M
37.51M
40.54M
33.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
233.62M
248.91M
230.57M
262.94M
Operating expense
273.62M
286.42M
271.17M
296.61M
Total operating expenses
763.86M
781.45M
735.35M
759.41M
Operating income
108.87M
98.57M
91.28M
111.74M
Other non operating income
553.00K
13.89M
1.91M
-5.70M
EBT including unusual items
105.00M
105.85M
88.53M
106.97M
EBT excluding unusual items
105.69M
105.82M
88.52M
107.06M
Income tax expense
24.32M
6.94M
20.28M
16.49M
Effective tax rate
23.16%
6.56%
22.91%
15.42%
Other operating expenses
-
-
-
-
Net income
83.35M
101.95M
73.80M
92.57M
Net profit margin
9.55%
11.59%
8.93%
10.63%
Earnings per share
-
-
-
-
Interest and investment income
2.38M
3.44M
3.74M
3.50M
Interest expense
-8.31M
-7.80M
-7.21M
-6.00K
Net interest expenses
-5.93M
-4.35M
-3.47M
3.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
168.79M
159.15M
152.37M
173.65M
Gain or loss from assets sale
710.00K
5.00K
-4.00K
129.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps